Sanofi recalls vaccine; BMS get EU approval for Orencia;

@FiercePharma: Takeda continues buying spree, picks up LigoCyte. More | Follow @FiercePharma

@EricPFierce: Australia Mayne Pharma buying SC-based CDMO Metrics for $105 million plus milestone. More | Follow @EricPFierce

> Sanofi Pasteur is recalling several batches of its typhoid fever vaccine saying they may not reach potency specifications. Story

> A study suggests a single injection of Allergan's ($AGN) Botox can help reduce urinary incontinence as effectively as daily drugs, perhaps setting the cosmetic drug up for a new use. Story

> Bristol-Myers Squibb ($BMY) says the European Commission has approved its subcutaneous formulation of Orencia for treatment of moderate to severe rheumatoid arthritis (RA). Item

> GlaxoSmithKline ($GSK) has officially ended its development of an experimental antibiotic after halting enrollment in trials for the candidate early this year, handing back the asset to Anacor Pharmaceuticals ($ANAC). Story

>The FTC is asking the Supreme Court to review lower court decisions saying that when Solvay Pharmaceuticals settled with generic drugmakers over its testosterone treatment, they were not anti-competitive. Story 

Biotech News

 @FierceBiotech: Sanofi stands up for diabetes therapy in crowded GLP-1 contest. More | Follow @FierceBiotech

 @JohnCFierce: Anacor gets an antibiotic back from Glaxo after microbiological resistance was seen in a study. Worthless now. More | Follow @JohnCFierce

 @RyanMFierce: Takeda builds up new vaccine unit with $60M LigoCyte buyout, with interview quotes. Article | Follow @RyanMFierce

> Defining 'fierce' in the modern age of drug and device development. Editor's Corner

> The Medicines Co. abandons blood-loss drug over safety risk. More

Medical Device News

 @FierceMedDev: Renal denervation's not just for hypertension--docs say it could help diabetics, too. More | Follow @FierceMedDev

 @MarkHFierce: Ilex will sell Novartis' blood test Dx kits in 16 African countries. More | Follow @MarkHFierce

 @DamianFierce: According to a new study, women fare worse with stents than men. More | Follow @DamianFierce

> Given Imaging grabs SmartPill Corp. for $6M. Story

> New math models aid artifical pancreas development. Item

And Finally... The outbreak of meningitis, tied to a drug made by a pharmacy compounder, is raising questions about whether compounders need to be better regulated. Story